J342A Open for Recruitment
Smoking habit: Non / Ex-smoker only
20 - 65
BMI : 18.50 - 32.00
Food restrictions : Fast
This study drug, nintedanib, is an investigational drug to treat idiopathic pulmonary fibrosis, which is characterized by a progressive decline in lung function.
Dose: 150 mg nintedanib
This is preliminary information and changes could occur without notice